Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 8 Colorectal Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Neoplasms 3 Smoking Cessation 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Motor Activity 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Colonic Neoplasms 2 Wilms Tumor 1 Venous Thromboembolism 1 Uveal Melanoma 1 Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer 1 Recurrence 1 Pulmonary Disease, Chronic Obstructive 1 Opioid-Related Disorders 1 Neuroblastoma 1 Neoplastic Cells, Circulating 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Inflammation 1 Hodgkin Disease 1 Hepatic Veno-Occlusive Disease 1 HPV Positive Oropharyngeal Squamous Cell Carcinoma 1 Fibrosis 1

Interventions

Ipilimumab 29 Nivolumab 23 pembrolizumab 14 incomplete Freund's adjuvant 10 Cyclophosphamide 10 Interleukin-2 9 Melphalan 8 CTLA-4 Antigen 8 sargramostim 7 Temozolomide 7 MART-1 Antigen 7 Dacarbazine 7 tebentafusp 6 Ranibizumab 6 montanide ISA 51 5 fludarabine phosphate 5 fludarabine 5 Sunitinib 5 Radiosurgery 5 Carboplatin 5 Bevacizumab 5 aldesleukin 4 aflibercept 4 Magnetic Resonance Spectroscopy 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Blood Specimen Collection 4 Biopsy 4 trametinib 3 sotrastaurin 3 relatlimab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Uveal Melanoma × Hematologic Tests × Clear all

NCT04424719 2025-09-03

SALOME

Institut Curie

Phase NA Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡